Yoshida K, Yoshizawa G, Yamazaki Y, Fujikawa T, Tanabe A, Sakurai K
First Department of Surgery, Jikei University School of Medicine, Tokyo, Japan.
Surg Today. 1994;24(6):526-9. doi: 10.1007/BF01884572.
Even though the current limits of treatment for advanced stage neuroblastoma require an understanding of biology and new therapeutic approaches, few invasion models of human neuroblastoma (HNB) which evaluate experimental therapies have been reported. We describe herein a reproducible murine model of cranial invasion after the intraocular xenograft of HNB in congenitally athymic mice. Approximately 10 weeks after the intraocular injection of 5 x 10(6) NB-1 HNB cells, 70% (14/20) of the mice developed intracranial invasion with skull involvement. There was no operative mortality. Macroscopically, deformities of the cranium were revealed in all 14 mice, 5 of which developed exophthalmos. Microscopically, cranial invasion mainly involved the extradural space, skull, and orbita; however, brain involvement could not be seen, indicating that the dura may act as a barrier. These invasive characteristics are very similar to those seen in humans; thus, we believe that this model provides a useful tool for evaluating the biology of, and new therapeutic approaches against, cranial invasion of neuroblastoma in vivo.
尽管当前晚期神经母细胞瘤的治疗局限需要对生物学和新治疗方法有所认识,但很少有评估实验性疗法的人类神经母细胞瘤(HNB)侵袭模型被报道。在此,我们描述了一种在先天性无胸腺小鼠眼内异种移植HNB后建立的可重复的颅骨侵袭小鼠模型。在眼内注射5×10⁶个NB - 1 HNB细胞后约10周,70%(14/20)的小鼠发生了伴有颅骨受累的颅内侵袭。无手术死亡病例。宏观上,所有14只小鼠均显示颅骨畸形,其中5只出现眼球突出。微观上,颅骨侵袭主要累及硬膜外间隙、颅骨和眼眶;然而,未见脑受累,这表明硬膜可能起到屏障作用。这些侵袭特征与人类所见非常相似;因此,我们认为该模型为在体内评估神经母细胞瘤颅骨侵袭的生物学特性和新治疗方法提供了一个有用的工具。